Diabetic nephropathy: Management of end-stage renal failure with CAPD and Langerhans islets transplantation;Możliwości przeszczepiania wysp Langerhansa u chorych z nefropatia̧ cukrzycowa̧ dializowanych otrzewnowo

Polskie Archiwum Medycyny Wewnetrznej

Volumn 112, Issue SPEC. ISS., 2004, Pages 13-17

  Orlowski, Tadeusz ^a,b  

^a Biomedycznej Polskiej Akademia Nauk   (Poland)

^b NONE   (Poland)

Author keywords

Islet; Peritoneal dialysis; Transplantation

Indexed keywords

CYCLOSPORIN; DACLIZUMAB; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; RAPAMYCIN; TACROLIMUS;

CONFERENCE PAPER; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIABETIC NEPHROPATHY; DISEASE COURSE; GRAFT REJECTION; HUMAN; IMPLANT; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; PANCREAS ISLET; PANCREAS ISLET TRANSPLANTATION; CHRONIC KIDNEY FAILURE; KIDNEY TRANSPLANTATION; METHODOLOGY; POLAND; REVIEW; RISK FACTOR; TREATMENT OUTCOME;

DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; POLAND; RISK FACTORS; TREATMENT OUTCOME;

EID: 6344278356     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (37)

1. Brendel M.: Bezpośrednia informacja e-mailowa.
2. Wańkowicz Z.: Dializa otrzewnowa u chorych na cukrzycȩ. [w:] Nefrodiabetologia, (red.) E. Franek i F. Kokot, 81-95, Via Medica, Gdańsk 2003.
3. Nakai S., Shinzato T., Nagura Y. i wsp.: An overview of regular dialysis treatment in Japan. Therap Apher Dial., 2004, 8(1), 3.
4. Schmilz O., Hansen H.E., Orskov H. i wsp.: End-stage renal failure in diabetic nephropathy. Blood Purif, 1985, 3(1-3), 120-139.
5. Rowińska D., Czerwiński J., Durlik M.: Przeszczepienie nerki i trzustki chorym z nefropatia̧ cukrzycowa. Pol. Arch. Med. Wewn., 1999, (CH), Nr spec., 712-73.
6. Rutkowski B.: Epidemiologia schylłkowej niewydolności nerek w Polsce. Przegl. Epidemiol., 2002, 56 (suppl. 4, 67-75).
7. Wimmer F., Oberaigner W., Kramarz i wsp.: Regional variability in the incidence of end-stage renal disease. Nephrol Dial. Transplant., 2003, 18(8), 1562.
8. Vitullo F., Casino F.G., Di Matteo A. i wsp.: Epidemiology of end-stage renal disease in an interregional perspective. J. Nephrol., 2003, 16(6), 813-8.
9. Lillehei R.C., Ruiz J.O.: Pancreas. Rozdz. [w:] Transplantation, (red.) J.S. Najarian i R.L. Simmons, 627-645. Lea and Febiger, Filadelfia, 1972.
10. Robertson R.P.: Islet Transplantation as a Treatment for Diabetes. N. Engl. J. Med., 2004, 350, 694-705.
11. Sutherland D.E., Gruesner R.W., Dunn D.L. i wsp.: Lessons learned from more than 1,000 pancreas transplantations at a single institution. Ann. Surg. 2001, 233(4), 463-501.
12. Ziaja J., Marcinkowski W., Cierpka L., Wiccek A.: Wpływ jednoczesnego przeszczepienia trzustki i nerki na odleglłe powiklłania cukrzycy u chorych na cukrzycȩ insulinozalezna̧ Pol. Merkuriusz Lek., 2003, 15(89), 455-458.
13. White S.A., James R.F.L., Swift S.M. i wsp.: Human islet transplantation. Diabet. Med., 2001, 18, 78-103.
14. Najarian J.S., Sutherland D.E., Baumgartner D. i wsp.: Total or near total pancreatectomy and islet autotransplantation for treatment of chronic pancreatitis. Ann. Surg., 1980, 192, 526-542.
15. Largiader F., Kolb E., Binswanger U.: A long-term functioning human pancreatic islet allotransplant. Transplantation, 1980, 29, 76-77.
16. International Islet Transplant Registry Newsletter, 1999, 8, 1-20.
17. Shapiro A.M.J., Lakey J.R.T., Ryan E.A. i wsp.: Islet transplantation in seven patients with type I diabetes mellitus using a glucocorticoid free immunosuppressive regimen. N. Engl. J. Med., 2000, 343, 230-280.
18. Ryan E.A., Lakey J.R.T., Rajotte R.V. i wsp.: Clinical outcome and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes, 2001, 50(4), 710-719.
19. Ryan E.A., Lakey J.R. Paty B. W. i wsp.: Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes, 2002, 51, 2148-2157.
20. Rich S.J., Swift S., Thirdborough S.M. i wsp.: Islet cryopreservation. Transplant. Proc., 1994, 26, 823-824.
21. Takada M., Nadeau K.C., Hancock W.W. i wsp.: Effects of explosive brain death on cytokines activation of peripheral organs. Transplant., 1998, 65, 1533.
22. Matsumoto S., Zhang G., Qualley S. i wsp.: Analysis of donor factors affecting human islet isolation with current isolation protocol. Transplant. Proc. 2004, 36(4), 1034-1036.
23. Bretzel R.G., Brandhorst D., Branhorst H. i wsp.: Improved survival of intraportal pancreatic islet allografts in patients with type I diabetes mellitus by refined peritransplant management. J. Mol. Med., 1999, 77, 140-143.
24. Lakey J.R., Burridge P. W., Shapiro A.M.: Technical aspects of islet preparation and transplantation. Transpl. Int., 2003, 16(9), 613-632.
25. Handler S., Andersdon A.: Stimulation of cell replication in transplanted pancreatic islets by nicotinamide treatment. Transplant., 1988, 46 30-31.
26. Ariaz-Diaz J., Vara E., Garcia G. i wsp.: Pentoxifilline partially reverse the effect of tumor necrosis factor on human islets. Transplant Proc., 1994, 26, 698-700.
27. Knefel K., Moczulski D., Zukowska-Szczechowska E. i wsp.: Czy cia̧glła ambulatoryjna dializa otrzewnowa jest czynnikiem ryzyka cukrzycy typu 2 u chorych na przewleklła̧ niewydolnoś ć nerek? Diabet. Dośw. Klin., 2004, 4(1), 35-38.
28. Ponikvar R., Buturovic Ponikvar J.: Management of diabetic patients with haemodialysis, peritoneal dialysis, and renal transplantation. Nephrol. Dial. Transplant., 2001, 16 (suppl. 6), 94-96.
29. Wesseling K.M., Pierik R.G.J.M., Offerman J.J.G.: Laparoscopic therapy in CAPD patient with perforated appendicitis without removal of the peritoneal catheter. Nephrol. Dial. Transplant., 2001, 16 (suppl. 6), 94-96.
30. Larsen J., Lane J., Mack-Shipman L.: Pancreas and kidney transplantation. Curr. Diab. Rep., 2002, 2(4), 359-364.
31. Papalois B.E., Troppmann C., Greussner A.C. i wsp.: Long-term peritoneal dialysis before transplantation and intra-abdominai infection after simultaneous pancreas-kidney transplantation. Arch. Surg., 1996, 13(7), 761-766.
32. Wesselin K.M., Pierik R.G.J.M., Offerman J.J.G.: Laparoscopic therapy in CAPD patient with perforated appendicitis without removal of the peritoneal catheter. Nephrol. Dial. Transplant., 2000, 18, 1929-1933.
33. Robinson R.J., Leapman S.B., Wetherington G.M. i wsp.: Surgical considerations of continuous ambulatory peritoneal dialysis. Surgery., 1984, 96(4), 723-730.
34. Tang S., Leung J.C., Chan L.Y. i wsp.: Regulation of complement C3 and C4 synthesis in human peritoneal mesothelial cells by peritoneal dialysis fluid. Clin. Exp. Immunol., 2003, 136(56), 85-94.
35. Douzdijan V., Abecassis M.: Deep wound infections in simultaneous pancreas-kidney transplant recipients on peritoneal dialysis. Nephrol. Dial. Transplant., 1995, 10(4), 533-540.
36. Lui S.L., Yip P.S., Lam M.F. i wsp.: Feasibility of reinstitution of CAPD after partial hepatectomy in patients with malignant hepatic tumors. Perit. Dial. Int., 2003, 23(5), 504-506.
37. Sabat M., Godlewska E., Kinasiewicz J. i wsp.: Assessment of some porcine strains as donors of islets of Langerhans. Transplant. Proc., 2003, 35[6], 2343.